Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × durvalumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 22 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Carcinoma, Hepatocellular 9 Liver Neoplasms 5 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neoplasms 3 Breast Neoplasms 3 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Unresectable Hepatocellular Carcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignancies 1 Skin Neoplasms 1 Resectable Intrahepatic Cholangiocarcinoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Platinum-Resistant Lung Small Cell Carcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1 Node; Prostate 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1

Interventions

Cyclophosphamide 11 Rituximab 9 Specimen Handling 8 fludarabine 7 obinutuzumab 6 ibrutinib 6 Magnetic Resonance Spectroscopy 6 Biopsy 5 tazemetostat 4 palbociclib 4 glofitamab 4 fludarabine phosphate 4 X-Rays 4 Prednisone 4 Phantoms, Imaging 4 Lenalidomide 4 Doxorubicin 4 venetoclax 3 pirtobrutinib 3 olaparib 3 Vemurafenib 3 Nuclear Medicine Department, Hospital 3 Nivolumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 ulixertinib 2 tucatinib 2 tocilizumab 2 temsirolimus 2 polatuzumab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡